Latest content
-
Read
Top 8 biologics conferences of 2023 at a glance
Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and where they’ll happen, who’ll be there, and the main focus.
-
4:51WatchFour integrated technologies for Biologics developability assessment
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics
-
1:39WatchHow Coriolis Pharma screens a vast chemical library for stabilizing excipients
Discover how Coriolis Pharma found the best excipients to stabilize their monoclonal antibodies for long-term storage. You’ll learn about the importance of expanding the chemical space for excipients
-
1:31WatchHow Janssen optimizes the stability of a therapeutic mAb
Discover how Janssen improved the stability of a promising prostate cancer targeting mAb. You’ll learn why it is important to optimize stability measurements of a therapeutic mAb.
-
2:34WatchHow 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta
Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal buffer for a vaccine antigen target.
-
Read8 biologics conferences you won’t want to miss in 2023
When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeutics approvals, and big pharma news, but nothing matches the biologics conference experience.
-
ReadLearn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors
-
37:25WatchPut your challenging affinity screening campaigns back on track — after you’ve tried everything else
When you’re entrusted with developing therapeutics for challenging or undruggable targets, it’s a struggle to characterize molecular interactions. And it’s not for lack of effort or expertise — SPR an
-
ReadNanoTemper announces Monolith X with breakthrough Spectral Shift technology, enabling affinity measurements where other methods fail
NanoTemper Technologies introduced Monolith X, adding breakthrough Spectral Shift technology to their top-selling Monolith product line.
- Contact Specialist
-
2:20WatchIntroducing Monolith X - the only way to get binding affinities in solution using very minimal sample
-
Read
The only way to get binding affinities in solution using very minimal sample
-
Read
Select the best biologics candidates with high-quality, multi-parameter stability characterization
-
Read5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved
As a gene therapy scientist, you face an abundance of challenges when working to build an effective AAV therapeutic. Many steps of the development workflow have yet to be standardized and the...
-
Read
Characterize your PROTAC hook effect with flexible and in-solution affinity measurements for results you can trust
-
14:07WatchSerotyping: why, when, and how to assess your AAV therapeutic to get it approved
When you develop an AAV therapeutic, you need to assess many key parameters, or Critical Quality Attributes (CQAs), in order to track progress and, ultimately, get your therapeutic approved. As part
-
Read
Rely on Dianthus to overcome roadblocks in your PROTAC characterizations
-
ReadNanoTemper Technologies welcomes Andreas Schmitz as its first Chief Human Resources Officer
MUNICH, Germany, 18 May 2022 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, welcomes Andreas Schmitz as the first Chief Human...
-
Read8 Gene Therapy conferences you should attend in 2022
With the first AAV-based gene therapies approved, and new gene editing strategies emerging, it’s important to stay on top of the latest topics in this therapeutic area. Here are 8 gene therapy...
-
Read9 Targeted Protein Degradation conferences you don’t want to miss in 2022
With so much interest and investment in target protein degradation, a lot can happen in a year. Here are 9 conferences to get up-to-date on recent progress and the latest approaches. You’ll not...
-
ReadGet more information about your protein expression conditions in less time with Andromeda
Get more information about your protein expression conditions in less time with Andromeda
-
Loading more...
